- Home
- / CannPal Animal Therapeutics
CannPal Animal Therapeutics
CannPal Animal Therapeutics Summary
Company Summary
- Overview
- CannPal Animal Therapeutics is a pharmaceutical-focused animal health company developing plant-derived therapeutic products. It focuses on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet owners with clinically validated and standardized therapeutics.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2016
- HQ
- Double Bay, AU | view all locations
- Website
- https://cannpal.com/
- Cybersecurity rating
Table of Contents
Key People
Kate Adams, Non-Executive Director
Robert Clifford, Non-Executive Director
LocationsView all
1 location detected
Double Bay, NSW HQ
Australia
level 3/45A Bay St
CannPal Animal Therapeutics Financials
Summary Financials
- Gross profit (H1, 2021)
- $753.0K
- Net income (H1, 2021)
- ($273.0K)
- Cash (H1, 2021)
- $1.4M
- EBIT (H1, 2021)
- ($276.0K)